DEA Restarts Rulemaking on Six Synthetic Cannabinoids After Error in Publication

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Scheduling Actions

DEA Restarts Rulemaking on Six Synthetic Cannabinoids After Error in Publication

Ken Baumgartner

January 10, 2017 at 03:00:00 ET

A rulemaking that would temporarily place six synthetic cannabinoids in Schedule I has been restarted after an initial notice was erroneously published in the final rules section of the Federal Register, the Drug Enforcement Administration announced (82 Fed. Reg. 2218, 2280; Jan. 9, 2017). The substances — 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA —we... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

DEA Restarts Rulemaking on Six Synthetic Cannabinoids After Error in Publication

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT